Recordings of neurons in a little-studied part of the brain associated with memory show an unexpected increase in activity in older brains, a finding that may suggest a new target for therapies to combat memory loss.
A new study co-authored by a Northwestern Medicine scientist found no significant difference between two popular therapy regimens in patients with a subset of Hodgkin lymphoma.
In a new study, patients treated with one-fourth of the dose of beta-blockers tested in large clinical trials had a 20 to 25 percent increase in survival, indicating that dosing likely needs to be personalized for patients to get the best benefit.
Older adults who exercised regularly did not have better cognitive function than those who attended health education workshops, according to a study co-authored by Northwestern Medicine investigator Mary McDermott, MD, ’92 GME.
A trail of messenger molecules left behind by general immune system cells called neutrophils helps virus-specific T-cells reach tissues infected by influenza, reports a new study published in Science.
At the Fourth Annual Driskill Day, students, faculty members and alumni gathered to present research, recognize achievement and celebrate the Walter S. and Lucienne Driskill Graduate Training Program in Life Sciences.
A new imaging technique that allows for visualization of blood flow in real-time revealed that abnormal blood flow from the two-flap valve in bicuspid aortic valve disease can create weakness in the aorta.
Northwestern Medicine scientists received a five-year, $3.9 million grant from the National Institutes of Health to determine the optimal drug doses for treating pregnant women with depression.
A study co-authored by Northwestern Medicine scientist Rintaro Hashizume, MD, PhD, identified the EAG2 potassium channel as a target for treating medulloblastoma.
In a recent study, Northwestern Medicine scientists described a new process that explains how the adhesion between epithelial cells occurs.